A phase I, randomised, placebo controlled, crossover study to assess the effect of SRT2104 on exercise tolerance and muscle metabolism in subjects with type 2 diabetes.

Trial Profile

A phase I, randomised, placebo controlled, crossover study to assess the effect of SRT2104 on exercise tolerance and muscle metabolism in subjects with type 2 diabetes.

Suspended
Phase of Trial: Phase I

Latest Information Update: 15 Jun 2016

At a glance

  • Drugs SRT 2104 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms SRTAiD
  • Most Recent Events

    • 07 Jun 2013 Additional lead trial centre added as reported by United Kingdom Clinical Research Network record.
    • 26 Jul 2011 Status changed from not yet recruiting to suspended as reported by United Kingdom Clinical Research Network.
    • 30 Oct 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top